Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Cardiovascular·MeSH: Amyloidosis
3 drugs in development·2 companies·4 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Phase 1(1)
| Drug | Company |
|---|---|
| NTLA-2001 | Intellia Therapeutics, Inc. (NTLA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Transthyretin Amyloidosis (ATTR) With Cardiomyopathy?
BioSniper tracks 3 drugs in development for Transthyretin Amyloidosis (ATTR) With Cardiomyopathy across 2 companies.
How many clinical trials target Transthyretin Amyloidosis (ATTR) With Cardiomyopathy?
There are 4 clinical trials targeting Transthyretin Amyloidosis (ATTR) With Cardiomyopathy tracked by BioSniper.
Deep-dive into Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis